Home Infusion Therapy Market Size & Forecast Report - 2026 to 2030

The global home infusion therapy market size was valued at around USD 38.5 billion in 3034 and projected to grow at a significant CAGR of over 8% during the forecast period from 2025 to 2030. The Home Infusion Therapy Market is witnessing significant growth as patients increasingly seek treatment options that allow them to receive intravenous therapies in a home setting. Rising incidences of chronic conditions such as cancer, diabetes, and infections are driving demand for at-home administration of medications including anti-infectives, chemotherapy agents, and nutritional solutions. The shift toward cost-effective and patient-friendly care models is further accelerating the adoption of home infusion products.

Market Snapshot:

Market Drivers:

The growth of the global home infusion therapy market is being driven by the rising burden of chronic diseases such as cancer, diabetes, and infectious conditions that require long-term intravenous treatment. As hospitals and healthcare systems aim to reduce inpatient care costs and improve patient outcomes, there’s a strong shift toward home-based solutions. The aging global population, which is more susceptible to chronic illnesses, further fuels this demand. Patients increasingly prefer receiving treatments in the comfort of their homes, where therapy is less disruptive to daily life and often associated with fewer complications like hospital-acquired infections.

A key catalyst for this expansion is the advancement in smart and portable infusion technologies that make at-home therapy safer and more efficient. A notable example is the CURLIN 8000 Ambulatory Infusion System, which received FDA clearance in May 2024. Developed by Moog, the device supports multiple infusion routes—including intravenous, subcutaneous, and epidural—and integrates with the RxManager software to enable remote management, improved dosing accuracy, and better clinical oversight. These kinds of innovations reduce the burden on healthcare providers while enhancing patient independence, especially in rural or resource-limited settings. Combined with growing acceptance of telehealth and supportive reimbursement frameworks, such technological developments are accelerating the global shift to decentralized infusion care.

Market Trends:

Surge in Home-Based Chronic Disease Management

One of the most prominent trends driving the home infusion therapy market is the increasing preference for managing chronic illnesses in a home care setting. Conditions such as cancer, diabetes, congestive heart failure, and immune deficiencies often require regular intravenous (IV) therapies that were traditionally administered in hospitals or infusion centers. However, healthcare providers and patients are now moving toward home-based options to improve convenience, reduce hospitalization costs, and minimize the risk of hospital-acquired infections. This trend is particularly important for elderly populations and immunocompromised individuals who benefit significantly from being treated in the comfort and safety of their own homes.

Technological Advancements in Infusion Devices

Technology is transforming the capabilities of home infusion therapy. Innovations in ambulatory infusion pumps, such as smaller, lightweight, and more user-friendly devices, are enabling complex treatments to be safely administered at home. A recent and notable example is the CURLIN 8000 Ambulatory Infusion System by Moog, which received FDA clearance in May 2024. This device supports multiple administration routes—such as intravenous, subcutaneous, and epidural—and integrates with RxManager, a software platform that allows clinicians to monitor and manage infusion therapy remotely. These advances reduce the need for direct clinical supervision and enhance patient safety, making home infusion a viable option for more complex drug regimens.

Growing Use of Needleless Connectors

Infection control and patient safety are top priorities in infusion therapy. Needleless connectors are increasingly used in home settings as they eliminate the need for needles when connecting syringes or IV tubing to vascular access devices. This not only reduces the risk of needlestick injuries for caregivers but also lowers the chance of catheter-related bloodstream infections (CRBSIs), a serious and costly complication. Their ease of use and compliance with infection prevention guidelines are making needleless systems a standard component in modern home infusion setups, particularly for long-term therapies.

Expansion of Telehealth and Remote Monitoring

The integration of telemedicine with home infusion therapy is revolutionizing the way care is delivered. With digital platforms and connected devices, healthcare providers can monitor infusion parameters in real time, ensuring accurate dosage, patient compliance, and quick response to complications. This is especially beneficial for patients in rural or underserved regions where physical access to clinics is limited. Telehealth tools also facilitate remote education for caregivers and patients, reducing the learning curve for managing infusions at home. The synergy between home infusion and virtual care is streamlining workflow efficiency and expanding access to specialty care services.

Rising Demand for Oncology and Specialty Drug Infusions at Home

The growing use of biologics, specialty drugs, and advanced therapies has fueled the expansion of home-based infusion in complex areas like oncology, immunology, and neurology. Chemotherapy, which was once only administered in controlled clinical environments, is now increasingly delivered at home under proper guidance. This shift is made possible by advances in drug formulations, infusion pump technology, and supportive services such as remote monitoring and home nursing. Patients receiving treatments like immunoglobulin therapy, inotropic support, and parenteral nutrition also benefit from personalized, convenient care at home, reducing stress and improving overall treatment adherence.

Market Opportunities:

The global home infusion therapy market is witnessing expanded opportunities as healthcare systems around the world shift toward patient-centric, decentralized care. Rising demand for at-home treatment of chronic conditions—such as cancer, diabetes, and immune disorders—is pushing providers to invest in safer, more efficient home infusion solutions. Emerging regions like Asia-Pacific and Latin America present untapped potential, especially as governments increase healthcare funding and infrastructure. Companies that can offer reliable, easy-to-use infusion devices tailored to local healthcare settings—such as compact pumps and infection-resistant consumables—stand to benefit. There’s also growing opportunity in training programs and support services that help patients and caregivers manage complex therapies at home.

A major development underscoring this momentum is the May 2025 joint venture between ICU Medical and Otsuka Pharmaceutical Factory, which aims to create one of the world’s largest IV solution manufacturing networks in North America. With a planned production capacity of up to 1.4 billion units annually, the initiative is designed to bolster supply chain resilience, support new product launches, and enable faster response to demand surges for therapies like hydration, antibiotics, and nutrition support. In parallel, ongoing advances in AI-enabled infusion monitoring, telehealth integration, and remote dose management platforms are transforming home infusion into a connected care ecosystem—creating fresh opportunities for digital health startups, software vendors, and device manufacturers alike.

Market Insights:

By Product Type:

The global home infusion therapy market is bifurcated into product type, route of administration, application, and geography. On the basis of product type, the infusion pumps dominated the market in 2024, accounting for the largest share of revenue. These devices are essential for delivering precise and controlled doses of medication, fluids, or nutrients over extended periods, which is crucial in treating chronic conditions like cancer, infections, and gastrointestinal disorders. The dominance of infusion pumps stems from their versatility—they can be programmed for continuous, intermittent, or patient-controlled infusions, supporting a wide range of therapies from chemotherapy to parenteral nutrition. Their ability to minimize dosage errors and enhance patient safety makes them indispensable in home healthcare settings.

Recent technological advancements have further reinforced the position of infusion pumps as the leading product type. The development of smart, portable, and connected pumps—such as the CURLIN 8000, which received FDA clearance in 2024—enables remote monitoring, dose adjustment, and integration with telehealth platforms. These features are particularly valuable for reducing hospital visits, ensuring compliance, and enabling real-time clinical oversight in home environments. With ongoing innovation, ease of use, and adaptability across various therapies, infusion pumps continue to lead the market, offering both high clinical value and commercial scalability for manufacturers.

By Application:

On the basis of application, the global home infusion therapy market is further segmented into anti-infective, endocrinology, chemotherapy, enteral nutrition, parenteral nutrition, and others. The anti-infective therapy dominated the market in 2024, accounting for the largest share of the market. This dominance is primarily driven by the widespread use of intravenous antibiotics, antivirals, and antifungal treatments for managing severe infections such as cellulitis, sepsis, endocarditis, and osteomyelitis. Many of these conditions require long-term intravenous therapy, which can be safely administered at home with proper equipment and clinical guidance. The increasing preference for outpatient parenteral antimicrobial therapy (OPAT)—as a cost-effective and patient-friendly alternative to hospitalization—is a major contributor to the segment’s growth.

The segment’s dominance is further reinforced by the rising burden of infectious diseases, especially among elderly and immunocompromised populations. According to the Infectious Diseases Society of America, OPAT has become a standard of care in many healthcare systems, enabling hospitals to reduce bed occupancy and lower treatment costs. Additionally, advancements in infusion devices, infection control practices, and care coordination have enhanced the safety and efficiency of delivering anti-infectives at home. As the global population ages and antibiotic-resistant infections become more prevalent, the demand for home-based anti-infective infusion therapy is expected to remain strong and steady.

The home infusion therapy market research report presents the analysis of each segment from 2020 to 2030 considering 2024 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2025 to 2030.

Historical & Forecast Period

• 2020-23 – Historical Year
• 2024 – Base Year
• 2025-2030 – Forecast Period

Market Segmentation:

By Product Type:

• Infusion Pumps
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

By Route of Administration:

• Intramuscular
• Subcutaneously
• Epidural

By Application:

• Anti-Infective
• Endocrinology
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Geographically, the North America dominated the global home infusion therapy market in 2024, accounting for the largest share of over 1/2 of the market. This leadership is primarily attributed to the region’s advanced healthcare infrastructure, high adoption of home-based medical technologies, and a strong presence of key market players such as Baxter International, Option Care Health, and Moog Inc. The U.S., in particular, has a well-established reimbursement framework for home infusion therapies through Medicare and private insurers, which significantly supports market growth. Moreover, the growing preference among patients for home-based care due to its convenience and cost savings has fueled demand for infusion pumps, intravenous sets, and other at-home therapy solutions.

The region also benefits from a high prevalence of chronic diseases like cancer, diabetes, and infections requiring long-term infusion treatments. According to the CDC, nearly 6 in 10 adults in the U.S. have a chronic disease, making them potential candidates for home infusion therapy. The recent FDA clearance of innovative devices such as the CURLIN 8000 infusion pump in 2024 is a testament to North America’s commitment to medical innovation and safety in home care. Furthermore, the region’s adoption of digital health technologies, including telehealth and remote patient monitoring, enhances the efficiency and reliability of home infusion services—cementing North America’s dominant position in the market.

Competitive Landscape:

Some of the prominent market players operating in the global home infusion therapy market are Baxter International Inc., Option Care Health, Inc., B. Braun Melsungen AG, Moog Inc., and ICU Medical, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Baxter International Inc.
• Option Care Health, Inc.
• Braun Melsungen AG
• Moog Inc.
• ICU Medical, Inc.
• Fresenius Kabi
• Terumo Corporation
• Eli Lilly and Company
• Smiths Medical (ICU Medical)
• CareFusion Corporation (BD)
• Others

Key Questions Answered by Home Infusion Therapy Market Report

• Global home infusion therapy market forecasts from 2025-2030
• Regional market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the regions as mentioned above
• Home infusion therapy submarket forecasts from 2025-2030 covering the market by product type, route of administration, application, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level home infusion therapy markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market